Stock Scorecard



Stock Summary for Insulet Corporation (PODD) - $133.25 as of 9/29/2026 7:24:37 PM EST

Total Score

12 out of 30

Safety Score

56 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for PODD

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for PODD

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for PODD

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for PODD

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for PODD (56 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 7
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 4
Trading Volume (Max of 10) 9
Price to Earnings (Max of 10) 6
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for PODD

Insulet stock falls 1.13 percent as guidance concerns persist 9/29/2026 2:40:00 PM
Insulet Targets Type 2 Retention as Omnipod 6 and Global Growth Gain Momentum 9/25/2026 8:09:00 AM
Insulet stock heads into the open after a 0.1 percent rise 9/25/2026 6:43:00 AM
Bronstein, Gewirtz & Grossman, LLC Encourages Insulet Corporation (PODD) Stockholders to Inquire about Securities Investigation 9/24/2026 1:00:00 PM
How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? 9/24/2026 8:07:00 AM
STAAR Surgical Company (STAA) Stock Price, News, Quote & History 9/23/2026 7:46:00 PM
Insulet stock trades 60.9 percent below its 52-week high 9/23/2026 2:25:00 PM
Wells Fargo initiates Beta Bionics stock with overweight rating 9/23/2026 12:08:00 PM
Insulet stock heads into the open after a 0.8 percent drop 9/23/2026 5:39:00 AM
Insulet Amends Credit Facilities, Expands Revolving Commitments 9/22/2026 10:10:00 PM

Financial Details for PODD

Company Overview

Ticker PODD
Company Name Insulet Corporation
Country USA
Description Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company is headquartered in Acton, Massachusetts.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 6/30/2026
Next Earnings Date 11/5/2026

Stock Price History

Last Day Price 133.25
Price 4 Years Ago 294.39
Last Day Price Updated 9/29/2026 7:24:37 PM EST
Last Day Volume 1,724,759
Average Daily Volume 1,660,598
52-Week High 354.88
52-Week Low 126.40
Last Price to 52 Week Low 5.42%

Valuation Measures

Trailing PE 25.61
Industry PE 111.28
Sector PE 65.40
5-Year Average PE 82.94
Free Cash Flow Ratio 17.28
Industry Free Cash Flow Ratio 47.30
Sector Free Cash Flow Ratio 36.01
Current Ratio Most Recent Quarter 2.48
Total Cash Per Share 7.71
Book Value Per Share Most Recent Quarter 20.51
Price to Book Ratio 6.80
Industry Price to Book Ratio 3.91
Sector Price to Book Ratio 11.82
Price to Sales Ratio Twelve Trailing Months 3.10
Industry Price to Sales Ratio Twelve Trailing Months 31.90
Sector Price to Sales Ratio Twelve Trailing Months 42.89
Analyst Buy Ratings 11
Analyst Strong Buy Ratings 4

Share Statistics

Total Shares Outstanding 69,354,000
Market Capitalization 9,241,420,500
Institutional Ownership 107.11%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.68%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 328.60%
Annual Earnings Growth -40.93%
Reported EPS 12 Trailing Months 5.33
Reported EPS Past Year 3.08
Reported EPS Prior Year 4.98
Net Income Twelve Trailing Months 375,300,000
Net Income Past Year 247,100,000
Net Income Prior Year 418,300,000
Quarterly Revenue Growth YOY 23.50%
5-Year Revenue Growth 24.53%
Operating Margin Twelve Trailing Months 16.20%

Balance Sheet

Total Cash Most Recent Quarter 534,900,000
Total Cash Past Year 716,100,000
Total Cash Prior Year 953,400,000
Net Cash Position Most Recent Quarter -394,600,000
Net Cash Position Past Year -214,700,000
Long Term Debt Past Year 930,800,000
Long Term Debt Prior Year 1,296,100,000
Total Debt Most Recent Quarter 929,500,000
Equity to Debt Ratio Past Year 0.62
Equity to Debt Ratio Most Recent Quarter 0.60
Total Stockholder Equity Past Year 1,515,200,000
Total Stockholder Equity Prior Year 1,211,600,000
Total Stockholder Equity Most Recent Quarter 1,422,200,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 298,300,000
Free Cash Flow Per Share Twelve Trailing Months 4.30
Free Cash Flow Past Year 377,700,000
Free Cash Flow Prior Year 305,400,000

Options

Put/Call Ratio 2.03
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -2.81
MACD Signal -2.62
20-Day Bollinger Lower Band 128.94
20-Day Bollinger Middle Band 149.61
20-Day Bollinger Upper Band 170.28
Beta 1.08
RSI 38.45
50-Day SMA 216.41
150-Day SMA 233.02
200-Day SMA 240.06

System

Modified 9/25/2026 5:48:26 AM EST